Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft.
about
Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Promising oncolytic agents for metastatic breast cancer treatmentOncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing miceTargeting tumor vasculature through oncolytic virotherapy: recent advances.Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity.Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.Mechanistic modeling quantifies the influence of tumor growth kinetics on the response to anti-angiogenic treatment.TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgerymouse study identifies tumour growth kinetics as biomarkers for the outcome of anti-angiogenic treatment
P2860
Q26775030-7F7A6767-B1A5-49C7-97F6-8C50C429050AQ26830620-9E3B6D0C-A505-4B44-BEC8-2D3A5F246FF0Q36393363-B6ADF3F0-C38B-4A1F-B35F-779357D8D7D9Q37031932-A86058EC-AD56-48F5-913A-39334491EA1DQ37709761-DB16AC1A-AB50-4CD5-8507-6B82FDD85CFFQ38645375-1DCA0F48-C20F-4BDF-8A59-0302AE150EB3Q38657642-EB5EE53E-610D-4711-86D0-FA0E3BC39596Q47228068-D8F7BAA1-1165-48BE-89E0-57DA96DC8309Q52726523-214C5FF2-4275-4D21-831E-A6C7DC33E3EBQ57132503-FDF4F62A-DE69-4724-BCD8-14BDD47006F0Q58718463-07777167-6901-4945-A796-F77BAFCC15AF
P2860
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Combination therapy of oncolyt ...... an breast carcinoma xenograft.
@en
type
label
Combination therapy of oncolyt ...... an breast carcinoma xenograft.
@en
prefLabel
Combination therapy of oncolyt ...... an breast carcinoma xenograft.
@en
P2093
P2860
P921
P356
P1476
Combination therapy of oncolyt ...... an breast carcinoma xenograft.
@en
P2093
Akimasa Nakao
Akiyuki Kanzaki
Hideki Kasuya
Hiroyuki Sugimoto
Kazuo Yamamura
Maki Tanaka
Naoko Tsurumaru
Saori Fukuda
Shin Takeda
P2860
P304
P356
10.1002/IJC.29163
P577
2014-09-27T00:00:00Z